Indole-3-carbinol disrupts estrogen receptor-alpha dependent expression of insulin-like growth factor-1 receptor and insulin receptor substrate-1 and proliferation of human breast cancer cells.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Molecular and Cellular Endocrinology

• Publication date

  2012-11-05

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.mce.2012.07.008PMID 22835548PMCID PMC3684449
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Indole-3-carbinol downregulation of telomerase gene expression requires the inhibition of estrogen receptor-alpha and Sp1 transcription factor interactions within the hTERT promoter and mediates the G1 cell cycle arrest of human breast cancer cells.

  2011cited by this paper
• Mechanisms of endocrine resistance in breast cancer.

  2011cited by this paper
• ERα-associated protein networks.

  2011cited by this paper
• Indole-3-Carbinol Triggers Aryl Hydrocarbon Receptor-dependent Estrogen Receptor (ER)α Protein Degradation in Breast Cancer Cells Disrupting an ERα-GATA3 Transcriptional Cross-Regulatory Loop

  2010influential reference
• Minireview: modulation of hormone receptor signaling by dietary anticancer indoles.

  2009influential reference
• Estrogen Mediation of Breast Tumor Formation Involves Estrogen Receptor‐Dependent, as Well as Independent, Genotoxic Effects

  2009cited by this paper
• The insulin-like growth factor-I receptor as an oncogene

  2009cited by this paper
• Type 1 insulin‐like growth factor receptor signaling is essential for the development of the hippocampal formation and dentate gyrus

  2009cited by this paper
• Igf1r as a therapeutic target in a mouse model of basal-like breast cancer

  2009cited by this paper
• Reversibility and recurrence of IGF-IR-induced mammary tumors

  2009cited by this paper
• Crosstalk Between IGF1R and Estrogen Receptor Signaling in Breast Cancer

  2008cited by this paper
• Early aberrant insulin‐like growth factor signaling in the progression to endometrial carcinoma is augmented by tamoxifen

  2008cited by this paper
• Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.

  2008cited by this paper
• The Type 1 Insulin-Like Growth Factor Receptor Pathway

  2008cited by this paper
• Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells.

  2008cited by this paper
• The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer.

  2008cited by this paper
• Insulin receptor substrate 1 is an effector of sonic hedgehog mitogenic signaling in cerebellar neural precursors

  2008cited by this paper
• Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation

  2007cited by this paper
• Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation

  2007cited by this paper
• The estrogen receptor α:insulin receptor substrate 1 complex in breast cancer: structure–function relationships

  2007influential reference
• Oxygen Tension Regulates the Stability of Insulin Receptor Substrate-1 (IRS-1) through Caspase-mediated Cleavage*

  2007cited by this paper
• The estrogen receptor alpha:insulin receptor substrate 1 complex in breast cancer: structure-function relationships.

  2007influential reference
• IGF1R signalling and its inhibition.

  2006cited by this paper
• Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.

  2006cited by this paper
• Estrogen receptor α as a target for indole-3-carbinol

  2006influential reference
• Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.

  2006influential reference
• Estrogen receptor alpha as a target for indole-3-carbinol.

  2006influential reference
• Estrogen signaling multiple pathways to impact gene transcription.

  2006cited by this paper
• Medicinal chemistry approaches to target the kinase activity of IGF-1R.

  2006cited by this paper
• Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.

  2006cited by this paper
• Innovative agents in cancer prevention.

  2005cited by this paper
• Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor.

  2005cited by this paper
• Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti–IGF-IR antibody

  2005cited by this paper
• A novel regulation of IRS1 (insulin receptor substrate-1) expression following short term insulin administration.

  2005cited by this paper
• Discovery of a (1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity.

  2005cited by this paper
• Molecular Targets and Anticancer Potential of Indole-3-Carbinol and Its Derivatives

  2005cited by this paper
• Involvement of Insulin Receptor Substrate 2 in Mammary Tumor Metastasis

  2004cited by this paper
• Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.

  2004cited by this paper
• Nuclear insulin receptor substrate 1 interacts with estrogen receptor alpha at ERE promoters.

  2004influential reference
• Nuclear insulin receptor substrate 1 interacts with estrogen receptor α at ERE promoters

  2004influential reference
• Distinct roles for insulin and insulin-like growth factor-1 receptors in pancreatic beta-cell glucose sensing revealed by RNA silencing.

  2004cited by this paper
• Growth Inhibition of Human Prostate Cancer Cells in Human Adult Bone Implanted into Nonobese Diabetic/Severe Combined Immunodeficient Mice by a Ligand-Specific Antibody to Human Insulin-Like Growth Factors

  2004cited by this paper
• Indole-3-carbinol is a negative regulator of estrogen.

  2003cited by this paper
• A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.

  2003cited by this paper
• New mechanisms of signal transduction inhibitor action: receptor tyrosine kinase down-regulation and blockade of signal transactivation.

  2003cited by this paper
• Estradiol increases IRS-1 gene expression and insulin signaling in breast cancer cells.

  2001influential reference
• Indole-3-carbinol Inhibits CDK6 Expression in Human MCF-7 Breast Cancer Cells by Disrupting Sp1 Transcription Factor Interactions with a Composite Element in the CDK6 Gene Promoter*

  2001cited by this paper
• Ligand-, Cell-, and Estrogen Receptor Subtype (α/β)-dependent Activation at GC-rich (Sp1) Promoter Elements*

  2000cited by this paper
• Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements.

  2000cited by this paper
• Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth

  2000cited by this paper
• Indole-3-carbinol and tamoxifen cooperate to arrest the cell cycle of MCF-7 human breast cancer cells.

  1999cited by this paper
• Context-dependent Transcriptional Regulation*

  1999cited by this paper
• Transcriptional activation of functional endogenous estrogen receptor gene expression in MCF10AT cells: a model for early breast cancer.

  1998cited by this paper
• Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action.

  1997cited by this paper
• The localization of the insulin‐like growth factor receptor 1 (IGFR‐1) in benign and malignant breast tissue

  1997cited by this paper
• Type I insulin-like growth factor receptor gene expression in normal human breast tissue treated with oestrogen and progesterone.

  1997cited by this paper
• Polyethylene glycol conjugated insulin-like growth factor binding protein-1 (IGFBP-1) inhibits growth of breast cancer in athymic mice.

  1997cited by this paper
• Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells.

  1990influential reference

• Integrating structure-activity relationships, computational approaches, and experimental validation to unlock the therapeutic potential of indole-3-carbinol and its derivatives.

  2025cites this paper
• Protein profiling uncovers IGF-1R inhibition potential of 3-(2-furoyl)-indole scaffolds in hepatocellular carcinoma.

  2025cites this paper
• Natural Products for the Prevention, Treatment and Progression of Breast Cancer

  2023cites this paper
• A Comprehensive Review of Health-Benefiting Components in Rapeseed Oil

  2023cites this paper
• Hormonal regulation of telomerase activity and hTERT expression in steroid-regulated tissues and cancer

  2022cites this paper
• Anticancer properties of medicinal plants and their bioactive compounds against breast cancer: a review on recent investigations

  2022cites this paper
• The Role of Natural Products and Their Multitargeted Approach to Treat Solid Cancer

  2022cites this paper
• BROCCOLINING SHIFOBAXSH XUSUSIYATLARI

  2022cites this paper
• Paradigm Shift: an Overview on Nutrigenetics and Nutrigenomics

  2021cites this paper
• Targeting the Key Signaling Pathways in Breast Cancer Treatment Using Natural Agents

  2020cites this paper
• Mechanisms Underlying Biological Effects of Cruciferous Glucosinolate-Derived Isothiocyanates/Indoles: A Focus on Metabolic Syndrome

  2020cites this paper
• Brassica Bioactives Could Ameliorate the Chronic Inflammatory Condition of Endometriosis

  2020cites this paper
• Molecular Identification of Phytochemical for Anticancer Treatment.

  2020cites this paper
• Investigation of the efficacy of indole-3-carbinol on a rat model of endometriosis (experimental study)

  2020cites this paper
• Extraction and Quantification of Sulforaphane and Indole-3-Carbinol from Rapeseed Tissues Using QuEChERS Coupled with UHPLC-MS/MS

  2020cites this paper
• Protein- and growth-modulatory effects of carcinoma-associated fibroblasts on breast cancer cells: Role of interleukin-6

  2019cites this paper
• Natural products as important tyrosine kinase inhibitors.

  2019cites this paper
• Translational opportunities for broad‐spectrum natural phytochemicals and targeted agent combinations in breast cancer

  2018cites this paper
• Potential phytocompounds for developing breast cancer therapeutics: Nature’s healing touch

  2018cites this paper
• Chapter 11 – Detection of Prevented DNA Damage by Therapeutic Foods

  2018cites this paper
• Pharmacophore modeling for identification of anti-IGF-1R drugs and in-vitro validation of fulvestrant as a potential inhibitor

  2018cites this paper
• Effects of indole-3-carbinol on steroid hormone profile and tumor progression in a mice model of canine inflammatory mammarycancer

  2018cites this paper
• Anticarcinogenic effect of indole-3-carbinol (I3C) on human hepatocellular carcinoma SNU449 cells

  2018cites this paper
• Regulation of microRNA using promising dietary phytochemicals: Possible preventive and treatment option of malignant mesothelioma.

  2017cites this paper
• MECHANIZM DZIAŁANIA INDOLO-3-KARBINOLU I 3,3´-DIINDOLILOMETANU W CHEMOPREWENCJI CHORÓB NOWOTWOROWYCH

  2017cites this paper
• Dietary Natural Products for Prevention and Treatment of Breast Cancer

  2017cites this paper
• PLGA encapsulation and radioiodination of indole-3-carbinol: investigation of anticancerogenic effects against MCF7, Caco2 and PC3 cells by in vitro assays

  2017cites this paper
• Role of dietary bioactive natural products in estrogen receptor-positive breast cancer.

  2016cites this paper
• Genistein decreases basal hepatic cytochrome P450 1A1 protein expression and activity in Swiss Webster mice.

  2016cites this paper
• Global gene expression and morphological alterations in the mammary gland after gestational exposure to bisphenol A, genistein and indole-3-carbinol in female Sprague-Dawley offspring.

  2016cites this paper
• Dietary Indoles Suppress Delayed-Type Hypersensitivity by Inducing a Switch from Proinflammatory Th17 Cells to Anti-Inflammatory Regulatory T Cells through Regulation of MicroRNA

  2016cites this paper
• Dietary Natural Products for Prevention and Treatment of Liver Cancer

  2016cites this paper
• An Update on Potential Perspectives of Glucosinolates on Protection against Microbial Pathogens and Endocrine Dysfunctions in Humans

  2016cites this paper
• The Possible Chemosensitizing Effect of Different Doses of Indol-3-Carbinol on Transplantable Tumor Model Treated with Doxorubicin

  2016cites this paper
• Indole-3-Carbinol and Its Role in Chronic Diseases.

  2016cites this paper
• The Association Between Cruciferous Vegetables Intake and Breast Cancer Risk among Women with Familial Breast Cancer

  2016cites this paper
• Estudo da influência da morfologia de nanopartículas de sílica mesoporosa na liberação do anticancerígeno indol-3-carbinol

  2015cites this paper
• Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

  2015cites this paper
• through Regulation of MicroRNA Anti-Inflammatory Regulatory T Cells Proinflammatory Th17 Cells to Hypersensitivity by Inducing a Switch from Dietary Indoles Suppress Delayed-Type

  2015cites this paper
• Indole Derivatives as Anticancer Agents for Breast Cancer Therapy: A Review.

  2015cites this paper
• Scientific medicine in integrative treatment of erectile dysfunction

  2015cites this paper
• Estrogenic endocrine disruptors: Molecular mechanisms of action.

  2015cites this paper
• Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells

  2014cites this paper
• Natural products as potential cancer therapy enhancers: A preclinical update

  2014cites this paper
• Use of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues: promising options for prevention and treatment of uterine fibroids?

  2014cites this paper
• Recommendations for Cancer Prevention Associated with Known Chronic Disease Biomarkers in Healthy Women ?

  2014cites this paper
• The Anti-Carcinogenic Effect of Indole-3-Carbinol and 3, 3'-Diindolylmethane and their Mechanism of Action

  2014cites this paper
• Effects of cultivation strategies on phytochemicals and sensory properties of cabbage ( Brassica oleracea L. var. capitata L.) and curly kale ( Brassica oleracea L. var. sabellica L.)

  2014cites this paper
• The Links Between Insulin Resistance, Diabetes, and Cancer

  2013cites this paper
• Phytochemical Regulation of Tumor Suppressive MicroRNA in Human Breast Cancer Cells

  2013cites this paper
• Progression of the erectile dysfunction in the population and the possibilities of its regression with bioregeneration.

  2013cites this paper
• Indole-3-Carbinol Exerts Sex-Specific Effects in Murine Colitis

  2012cites this paper